Absci Corporation and Owkin have announced a partnership bringing together two leading AI platforms to rapidly discover and design novel therapeutics for patients.
FUJIFILM Diosynth Biotechnologies has announced an expansion of its operations, a move that marks a pivotal moment in its journey as a leader in pharmaceuticals.
Antag Therapeutics, a biopharmaceutical company pioneering novel treatments for obesity, has announced the appointment of Joerg Moeller, MD, PhD, as chief executive officer, effective immediately.
Pharmapack Europe & CPHI have outlined key trends for pharma in 2025, highlighting the return of funding liquidity—via increased VC investments and PE capital for M&A.
GEODIS, specialist in transport and logistics, announces the appointment of Marc Vollet as executive vice-president of GEODIS’s European Road Network Line of Business.
Molex, a parent to Phillips Medisize, announced that it has completed, through an affiliate, the previously announced acquisition of Vectura Group from Vectura Fertin Pharma, a subsidiary of Philip Morris International.
Pioneer Group has announced a collaboration agreement with Thermo Fisher Scientific to support biotech founders on their journey towards commercialising intellectual property in the healthcare and sustainability sectors.
Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, has announced capacity expansions at its sites in Rewari (IN) and Suzhou (CN).
Gaelic Laboratories, a European CMO based in Ireland, has established a subsidiary in the UAE, enabling access to the Middle East market – both for Gaelic Laboratories and its marketing partners looking to access this rapidly-growing region.
ACG, a supplier of integrated manufacturing solutions for the pharmaceutical and nutraceutical industries, has announced the commencement of operations at its capsule manufacturing facility in Rayong, Thailand.
Evaluate, a provider of market insights for the pharmaceutical industry, has released its 2025 Preview report featuring updated forecasts for the biopharma market for 2025.
